@T Brown
Multiple pies on offer:
1. Licensing deal objective - upcoming asiabio invest presentation
2. Positive Phase 2 trial results of SM6 likely. A rare thing. Could result in Amgen maneuver, significant value proposition. Orphan drug status, fast tracked through regulatory requirements, speed to market.
3. Diagnostic PoC - collaboration with Mac Uni. Would not be surprised if an announcement was around the corner.
massive buy, page-23
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
-0.001(14.3%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $1.953K | 325.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4291214 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 500160 | 1 |
View Market Depth
| Last trade - 11.14am 06/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |